Last updated on 13 Nov, 2025 | 05:19 IST
Rights Ratio | Face Value  | Premium | Ex-Right Date | Record Date  | Announcement Date |
|---|---|---|---|---|---|
| No data found | |||||
*Disclaimer: The information listed is solely for research purposes and are not recommendations. Please conduct your own research before making any investment decisions.
Existing shareholders of Concord Biotech as of the record date are eligible to participate in a rights issue allowing them to purchase additional shares often at a discount.
Shareholders can apply for Concord Biotech rights issue by following the company instructions, typically by submitting an application form and making the payment within the specified period.
No! Participation in Concord Biotech rights issue is not mandatory, but voluntary. However, shareholders can choose to exercise their rights, sell them, or let them expire.
No, Concord Biotech hasn’t had any right issues as of {{current_date}} in last 2023-2025
No, Concord Biotech hasn’t had any right issues as of {{current_date}} in last 2023-2025